Genomic study reveals important similarities and differences in ovarian cancer mutations across populations
Peer-Reviewed Publication
Updates every hour. Last Updated: 11-Jul-2025 00:10 ET (11-Jul-2025 04:10 GMT/UTC)
Metabolic dysfunction-associated fatty liver disease (MAFLD) has become a growing global health concern, affecting millions worldwide. This complex liver disorder ranges from simple steatosis to more severe forms, including metabolic dysfunction-associated steatohepatitis (MASH), which may progress to fibrosis, cirrhosis, and even liver cancer. The latest insights into transcription factors provide a deeper understanding of the disease’s progression and potential therapeutic interventions.